These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 9414670

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. OKT3 antibody response study: comparative testing of human antimouse antibody.
    Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W.
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):74-6. PubMed ID: 8465432
    [No Abstract] [Full Text] [Related]

  • 3. The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantation.
    Kimball JA, Norman DJ, Shield CF, Schroeder TJ, Lisi P, Garovoy M, O'Connell JB, Stuart F, McDiarmid SV, Wall W.
    Transpl Immunol; 1995 Sep; 3(3):212-21. PubMed ID: 8581409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Consensus statement regarding OKT3-induced cytokine-release syndrome and human antimouse antibodies.
    Norman DJ, Chatenoud L, Cohen D, Goldman M, Shield CF.
    Transplant Proc; 1993 Apr; 25(2 Suppl 1):89-92. PubMed ID: 8465436
    [No Abstract] [Full Text] [Related]

  • 10. Optimal timing for surveillance endomyocardial biopsies in heart transplant patients receiving antithymocyte globulin induction.
    Cantarovich M, de Gruchy S, Forbes C, Marpole D, Elstein E, Magnan C, de Varennes B.
    Transplant Proc; 1999 Apr; 31(1-2):79. PubMed ID: 10083015
    [No Abstract] [Full Text] [Related]

  • 11. Human anti-mouse antibodies interferences in Elecsys PTH assay after OKT3 treatment.
    Cavalier E, Carlisi A, Chapelle JP, Orfanos P, Uzan M, Falque V, Delanaye P, Hachicha M.
    Transplantation; 2009 Feb 15; 87(3):451-2. PubMed ID: 19202453
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Grade 2 cellular heart rejection: does it exist?: Yes!
    Kemnitz J.
    J Heart Lung Transplant; 1995 Feb 15; 14(4):800-1. PubMed ID: 7578197
    [No Abstract] [Full Text] [Related]

  • 15. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies.
    Colvin RB, Preffer FI.
    Clin Lab Med; 1991 Sep 15; 11(3):693-714. PubMed ID: 1934971
    [Abstract] [Full Text] [Related]

  • 16. Induction immunotherapy in heart transplantation with T10B9.1A-31: a phase I study.
    Waid TH, Thompson JS, McKeown JW, Brown SA, Sekela ME.
    J Heart Lung Transplant; 1997 Sep 15; 16(9):913-6. PubMed ID: 9322140
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The IgE humoral response in OKT3-treated patients. Incidence and fine specificity.
    Abramowicz D, Crusiaux A, Niaudet P, Kreis H, Chatenoud L, Goldman M.
    Transplantation; 1996 Feb 27; 61(4):577-81. PubMed ID: 8610384
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.